Rasina Therapeuctics Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2019.
2019 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Rasina Therapeuctics Private Limited

Rasina Therapeuctics Private Limited, a struck off private limited company, was established on 25 July 2019 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230TG2019PTC134362. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.53 M and a paid-up capital of ₹0.53 M.

Its leadership includes Archana Bala Adavikolanu (Nominee Director), Vikash Kumar Agarwal (Comp. Inc. Oi As Promoter), Vinayak Dinesh Dendukuri (Nominee Director). Past directors included Kiranmai Kakarlapudi Penmetsa. It is based at 8-2-293 B2/Nl/46,Yousufguda., Hyderabad, Telangana, 500045.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG2019PTC134362

  • Registration Number

    134362

  • Incorporation Date

    25 July 2019

  • Authorized Capital

    ₹0.53 M

  • Paid-Up Capital

    ₹0.53 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.53 M
  • Paid Up Capital ₹ 0.53 M
  • Company Age 6 Year, 7 Months
Company report

Rasina Therapeuctics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rasina Therapeuctics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rasina Therapeuctics Private Limited?
Current Directors
Name Designation Appointment Date Status
Archana Bala Adavikolanu Nominee Director 25 Jul 2019 Current
Vikash Kumar Agarwal Comp. Inc. Oi As Promoter 25 Jul 2019 Current
Vinayak Dinesh Dendukuri Nominee Director 25 Jul 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee Director 06 Nov 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rasina Therapeuctics.

Enhance accessibility to Rasina Therapeuctics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Rasina Therapeuctics revenue growth over time
Rasina Therapeuctics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rasina Therapeuctics?

Unlock access to Rasina Therapeuctics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rasina Therapeuctics?

Unlock and access historical data on people associated with Rasina Therapeuctics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rasina Therapeuctics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rasina Therapeuctics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rasina Therapeuctics
Recent Activity within the Organization
  • Director Appointment

    The activity Archana Bala Adavikolanu was appointed as a Nominee Director was appointed as a Nominee Director on 25 Jul 2019 & has been associated with this company since 6 years 7 months . was completed.

  • Director Appointment

    The activity Vikash Kumar Agarwal was appointed as a Comp. Inc. OI as Promoter was appointed as a Comp. Inc. OI as Promoter on 25 Jul 2019 & has been associated with this company since 6 years 7 months . was completed.

  • Director Appointment

    The activity Vinayak Dinesh Dendukuri was appointed as a Nominee Director was appointed as a Nominee Director on 25 Jul 2019 & has been associated with this company since 6 years 7 months . was completed.

  • Company Incorporation

    The activity Rasina Therapeuctics Private Limited was registered on 25 Jul 2019 with Roc Hyderabad & aged 6 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rasina Therapeuctics Private Limited?

The CIN of Rasina Therapeuctics Private Limited is U24230TG2019PTC134362.

Where is Rasina Therapeuctics Private Limited headquartered?

Rasina Therapeuctics Private Limited is headquartered at 8-2-293 B2/Nl/46,Yousufguda., Hyderabad, Telangana, 500045.

When was Rasina Therapeuctics Private Limited incorporated?

Rasina Therapeuctics Private Limited was incorporated on 25 July 2019.

Who are the current directors of Rasina Therapeuctics Private Limited?

The current directors of Rasina Therapeuctics Private Limited are

What is the primary industry of Rasina Therapeuctics Private Limited?

The primary industry of Rasina Therapeuctics Private Limited is Chemicals.

Is Rasina Therapeuctics Private Limited a listed company?

Rasina Therapeuctics Private Limited is unlisted.

What is the capital structure of Rasina Therapeuctics Private Limited?

The authorized capital of Rasina Therapeuctics Private Limited is ₹0.53 M, and the paid-up capital is ₹0.53 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available